Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Post by AndrewKenon Apr 17, 2020 1:47am
303 Views
Post# 30920298

ABC FOX News

ABC FOX Newshttps://www.montanarightnow.com/all_abc_fox/butte-respiratory-specialist-working-on-coronavirus-stem-cell-trial/article_a1a9f18a-7f4f-11ea-8dda-e702386a988b.html


BUTTE - To help combat the coronavirus outbreak, a Belgrade biologics company has recruited a Butte respiratory specialist to help with a free stem cell clinical trial in Montana.

Lattice Biologics is a company based in Belgrade that produces regenerative tissues or stem cell products for the United States and across the world.

The company has recruited Butte respiratory and pulmonary specialist Chad Green to help with a free clinical trial to test the safety and efficacy of stem cell technology in fighting Covid-19.

 

"We're optimistic about our positive results, and you know ultimately this won't benefit just Montanans, but people throughout the world," said Green.

Enrollment is now open for the trial, and Green says they need more subjects enrolled to start conducting the studies.

 

Once phase one of the trial begins, they hope to have results in about two weeks. The Montana study is one of three being conducted worldwide by the company.

"Well I think it is very important, time is of the essence in order to get good results quickly and know if this is a possible scenario that we can treat it," said Green.

Candidates for the trial must have a lab-confirmed coronavirus diagnosis and lung involvement that has required oxygen or mechanical ventilation. Green says he will screen patients to see if they qualify for the trial.

If you believe you qualify for the trial, you can head over to Lattice Biologics website for more information.

<< Previous
Bullboard Posts
Next >>